No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Cardiology

• Publication date

  2010-11-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2009.07.023PMID 19712983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ethical authorship and publishing.

  2009cited by this paper
• Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats.

  2006cited by this paper
• Effect of pravastatin on left ventricular mass in the two-kidney, one-clip hypertensive rats.

  2006cited by this paper
• Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives.

  2005cited by this paper
• Effect of simvastatin on left ventricular mass in hypercholesterolemic rabbits.

  2005cited by this paper
• Atorvastatin Prevents End-Organ Injury in Salt-Sensitive Hypertension: Role of eNOS and Oxidant Stress

  2004cited by this paper
• Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.

  2004cited by this paper
• Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements

  2003cited by this paper
• Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy

  2003cited by this paper
• Impact of HMG CoA reductase inhibition on small GTPases in the heart.

  2002cited by this paper
• Association of Pravastatin and Left Ventricular Mass in Hypercholesterolemic Patients: Role of 8-Iso-Prostaglandin F2&agr; Formation

  2002cited by this paper
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor Simvastatin Prevents Cardiac Hypertrophy Induced by Pressure Overload and Inhibits p21 ras Activation

  2002cited by this paper
• Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.

  2001cited by this paper
• Amelioration of Angiotensin II–Induced Cardiac Injury by a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor

  2001cited by this paper
• Cardiac atrophy after bed rest and spaceflight.

  2001cited by this paper
• Simvastatin inhibits noradrenaline‐induced hypertrophy of cultured neonatal rat cardiomyocytes

  2001cited by this paper
• Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension.

  2000cited by this paper
• Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells.

  1999cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• A formula to estimate the approximate surface area if height and weight be known

  1989cited by this paper
• Standardization of M-mode echocardiographic left ventricular anatomic measurements.

  1984cited by this paper
• CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN

  1916cited by this paper

• The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta‐analysis of randomized controlled trials

  2019cites this paper
• Adiponectin and Aldosterone in Left Ventricular Hypertrophy: An Intriguing Interplay

  2018cites this paper
• New statin use and left ventricular structure: Estimating long‐term associations in the Multi‐Ethnic Study of Atherosclerosis (MESA)

  2018cites this paper
• Hypertension, Left Ventricular Hypertrophy, and Myocardial Ischemia.

  2017cites this paper
• Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

  2015cites this paper
• Targeting cardiac hypertrophy: toward a causal heart failure therapy.

  2014influential citation
• Statins in heart failure--With preserved and reduced ejection fraction. An update.

  2014cites this paper
• Left-atrial wall thickening may be an important-response in systemic hypertension as well as left-ventricular hypertrophy and more remarkable than left-ventricular diastolic dysfunction and left-atrial enlargement.

  2013cites this paper